Science Explorer Back to mapMap
Discussion
Researcher · Centre Léon Bérard · France

Séverine Tabone‐Eglinger

Séverine Tabone‐Eglinger publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Gastroenterology, on topics such as Gastrointestinal Tumor Research and Treatment, Cancer Genomics and Diagnostics and Sarcoma Diagnosis and Treatment.

ORCID 0000-0003-4247-1321 OpenAlex
World rank
#1,473,662
of 7,710,434 ranked researchers
Rank in France
#66,246
of 324,115
Works
80
Citations
1k
Citations per work
13.0
h-index
18
i10-index 31Top 23% in Pulmonary and Respiratory Medicine
Séverine Tabone‐Eglinger

What does Séverine Tabone‐Eglinger research?

Séverine Tabone‐Eglinger's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (17%).

Health Sciences: 38 works · 46.9% of their workMedicine: 38 works · 46.9% of their workPulmonary and Respiratory Medicine: 13 works · 16.1% of their workOncology: 12 works · 14.6% of their workGastroenterology: 7 works · 8.9% of their workSurgery: 6 works · 7.3% of their workEverything else: 29 works · 36.5% of their workLife Sciences: 13 works · 16.6% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 16.6% of their workCancer Research: 7 works · 8.3% of their workMolecular Biology: 7 works · 8.3% of their workTHEIR WORKSéverineTabone‐Eglinger80works
Life Sciences17%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3846.9%
  2. Everything else2936.5%
    1. Biochemistry, Genetics and Molecular Biology1316.6%
  1. 1Pulmonary and Respiratory Medicine16% of their works
  2. 2Oncology15% of their works
  3. 3Gastroenterology9% of their works
  4. 4Molecular Biology8% of their works
  5. 5Cancer Research8% of their works
  6. 6Surgery7% of their works

Research topics

Which keywords describe Séverine Tabone‐Eglinger's research?

The keywords of their largest research topics: Prognostic Factors, Chemotherapy, Imatinib Mesylate, Sunitinib, Clinical Practice Guidelines, Cancer Genomics, Mutational Signatures and Survival Analysis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors252 topics
  2. Chemotherapy223 topics
  3. Imatinib Mesylate161 topic
  4. Sunitinib161 topic
  5. Clinical Practice Guidelines152 topics
  6. Cancer Genomics141 topic
  7. Mutational Signatures141 topic
  8. Survival Analysis112 topics
  9. Osteosarcoma91 topic
  10. Soft Tissue Sarcoma91 topic
  11. Intussusception81 topic
  12. Meckel's Diverticulum81 topic
  13. Pancreatic Cancer71 topic
  14. Surgical Complications71 topic
  15. Allergic Disease61 topic
  16. Endoscopic Resection61 topic
  17. Gastric Cancer61 topic
  18. Mast Cells61 topic
  19. Neuroendocrine Tumors51 topic
  20. Pancreatic Neuroendocrine Tumors51 topic

Where does Séverine Tabone‐Eglinger work?

Séverine Tabone‐Eglinger's main affiliation in the publication record is Centre Léon Bérard, France.

How many publications and citations does Séverine Tabone‐Eglinger have?

OpenAlex counts 80 works and 1,040 citations for Séverine Tabone‐Eglinger, an h-index of 18, ranking #1,473,662 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Séverine Tabone‐Eglinger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.